Board members

The members of the International PNH Interest Group Board of Directors are recognized experts in the care and management of PNH. Together, they bring to IPIG a vast depth and breadth of knowledge about PNH and related conditions.

Board members are elected by IPIG members at the Annual Meeting of Members for terms of three years and are eligible for successive terms. To ensure adequate member representation, at least one director is elected from each of three geographic areas: Europe, Asia-Pacific, and North America.

Peter Hillmen

Chairman MB, ChB, PhD Leeds Teaching Hospitals NHS Trust
Leeds
United Kingdom

Petra Muus

MD, PhD Nijmegen
Netherlands

Shinji Nakao

MD, PhD Cellular Transplantation Biology
Kanazawa University Graduate School of Medical Science
Kanazawa
Ishikawa
Japan

Charles J. Parker

Treasurer MD Division of Hematology and Bone Marrow Transplantation
University of Utah School of Medicine
Salt Lake City
Utah
USA

Régis Peffault de Latour

MD, PhD Hematology-Bone Marrow Transplantation
Research Institute for Microbial Diseases
Hôpital Saint-Louis
Paris
France

Antonio M. Risitano

MD, PhD Division of Hematology
Federico II University
Naples
Italy

Russell E. Ware

MD, PhD Cincinnati Children’s Hospital
Cincinnati, OH
USA

Neal S. Young

MD Washington DC
USA

Help us expand our Resources

If you have information or resources you’d like to submit for inclusion on our IPIG website, our board will be happy to consider your submission.

Find out how to submit a resource